The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-aminoethyl)-N-benzyl-1-methyl-1,4-dihydrochromeno[4,3-c]pyrazole-3-carboxamide ID: ALA4524552
PubChem CID: 155520144
Max Phase: Preclinical
Molecular Formula: C21H22N4O2
Molecular Weight: 362.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cn1nc(C(=O)N(CCN)Cc2ccccc2)c2c1-c1ccccc1OC2
Standard InChI: InChI=1S/C21H22N4O2/c1-24-20-16-9-5-6-10-18(16)27-14-17(20)19(23-24)21(26)25(12-11-22)13-15-7-3-2-4-8-15/h2-10H,11-14,22H2,1H3
Standard InChI Key: NPZOLEBIGLVKET-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
18.1763 -13.1659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3477 -12.3486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3466 -13.1682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0546 -13.5771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0529 -11.9398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7615 -12.3450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7603 -13.1657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4665 -13.5747 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.4688 -11.9334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1778 -12.3429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7863 -11.7952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4534 -11.0471 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6392 -11.1327 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.6002 -11.7915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0120 -12.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.0056 -11.0819 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.8292 -12.4937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2410 -13.1995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0581 -13.1958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.6066 -13.2069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0184 -13.9128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6109 -14.6177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0220 -15.3231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8401 -15.3199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2453 -14.6053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8318 -13.9029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0925 -10.5253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
6 9 1 0
7 8 1 0
8 1 1 0
1 10 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 9 1 0
11 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
17 18 1 0
18 19 1 0
15 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
13 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 362.43Molecular Weight (Monoisotopic): 362.1743AlogP: 2.58#Rotatable Bonds: 5Polar Surface Area: 73.38Molecular Species: BASEHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.15CX LogP: 2.17CX LogD: 0.43Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.76Np Likeness Score: -1.04
References 1. Chianelli D, Rucker PV, Roland J, Tully DC, Nelson J, Liu X, Bursulaya B, Hernandez ED, Wu J, Prashad M, Schlama T, Liu Y, Chu A, Schmeits J, Huang DJ, Hill R, Bao D, Zoll J, Kim Y, Groessl T, McNamara P, Liu B, Richmond W, Sancho-Martinez I, Phimister A, Seidel HM, Badman MK, Joseph SB, Laffitte B, Molteni V.. (2020) Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis., 63 (8): [PMID:31940200 ] [10.1021/acs.jmedchem.9b01621 ]